| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
March 31,
2026 |
| Accession Number: |
0001213900-26-036571 |
| Submission Type: |
POS AM |
| CIK: |
0001536196 |
| Company Name: |
Can-Fite BioPharma Ltd. |
| File Number: |
333-269485 |
|
